Bamco Inc Vertex Pharmaceuticals Inc Transaction History

Bamco Inc

$36.8 Billion
Q3 2024

A detailed history of Bamco Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bamco Inc holds 23,000 shares of VRTX stock, worth $10.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

23,000

Previous 23,000 -0.0%

Holding current value

$10.6 Million

Previous $10.8 Million 0.78%

% of portfolio

0.03%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $1.83 Million - $2.06 Million	6,400 Added 38.55%	23,000 $6.64 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $3.9 Million - $4.86 Million	16,600 New	16,600 $4.68 Million
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $11.3 Million - $13.3 Million	-60,113 Closed	0 $0
Q1 2021 May 19, 2021	SELL	$207.02 - $241.31 $15.8 Million - $18.4 Million	-76,256 Reduced 55.92%	60,113 $12.9 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $11 Million - $14.6 Million	53,018 Added 63.61%	136,369 $32.2 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $877,135 - $1.04 Million	3,431 Added 4.29%	83,351 $22.7 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $291,094 - $381,877	1,291 Added 1.64%	79,920 $23.2 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $1.21 Million - $1.5 Million	6,066 Added 8.36%	78,629 $18.7 Million
Q4 2019 Feb 18, 2020	SELL	$166.71 - $223.91 $920,572 - $1.24 Million	-5,522 Reduced 7.07%	72,563 $15.9 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $229,064 - $257,810	-1,378 Reduced 1.73%	78,085 $13.2 Million
Q2 2019 Aug 15, 2019	SELL	$164.61 - $190.37 $32,263 - $37,312	-196 Reduced 0.25%	79,463 $14.6 Million
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $1.19 Million - $1.41 Million	-7,248 Reduced 8.34%	79,659 $14.7 Million
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $75,195 - $95,143	495 Added 0.57%	86,907 $14.4 Million
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $446,161 - $512,688	2,660 Added 3.18%	86,412 $16.7 Million
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $3.15 Million - $3.67 Million	21,615 Added 34.79%	83,752 $14.2 Million
Q1 2018 May 09, 2018	BUY	$151.6 - $177.13 $2.84 Million - $3.32 Million	18,766 Added 43.27%	62,137 $10.1 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $1.87 Million - $2.11 Million	13,588 Added 45.62%	43,371 $6.5 Million
Q3 2017 Nov 15, 2017	BUY	$148.13 - $162.24 $4.41 Million - $4.83 Million	29,783	29,783 $4.53 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.

Account